uce
ProgressImage ProgressImage
Ajanta Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 532331 border-img ISIN Demat INE031B01049 border-img Book Value 290.22 border-img NSE Symbol AJANTPHARM border-img Div & Yield % 1.07 border-img Market Cap ( Cr.) 32946.82 border-img P/E 35.21 border-img EPS 74.92 border-img Face Value 2
Quarters
ParticularsJun 2025
()
Mar 2025
()
Dec 2024
()
Gross Sales1208.561013.941101.92
Other Operating Income0.000.000.00
Other Income 40.6317.9333.23
Total Income1249.191031.871135.15
Total Expenditure 879.16764.29765.59
PBIDT370.03267.58369.56
Interest 0.730.672.48
PBDT369.30266.91367.08
Depreciation40.3138.7634.93
Tax70.7339.1076.38
Fringe Benefit Tax0.000.000.00
Deferred Tax3.29-4.383.32
Reported Profit After Tax254.97193.43252.45
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item254.97193.43252.45
    
EPS (Unit Curr.)20.4115.4620.16
EPS (Adj) (Unit Curr.)20.4115.4620.16
Calculated EPS (Unit Curr.)20.3415.4320.14
Calculated EPS (Adj) (Unit Curr.)20.3415.4320.14
Calculated EPS (Ann.) (Unit Curr.)81.3661.7280.56
Calculated EPS (Adj) (Ann.) (Unit Curr.)81.3661.7280.56
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity25.0725.0725.07
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)30.6226.3933.54
PBDTM(%)30.5626.3233.31
PATM(%)21.1019.0822.91
x
x
×
Let's Chat
close
refresh